Document is current
Any future updates will be listed below
-
Authors
Stroth, Sanna https://orcid.org/0000-0002-0266-173X
Tauscher, Johannes
Wolff, Nicole
Küpper, Charlotte
Poustka, Luise
Roepke, Stefan
Roessner, Veit
Heider, Dominik
Kamp-Becker, Inge
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (FKZ 01EE1409A)
Philipps-Universität Marburg
- License Information
-
More Information
Article History
Received: 13 September 2021
Accepted: 22 February 2022
First Online: 7 March 2022
Declarations
:
: All data were analyzed anonymously, with approval from the local ethics committee (Az. 92/20). Due to the retrospective nature of data collection and analysis based on anonymized data, the need for informed consent was waived by the ethics committee. All methods were applied following relevant institutional and international research guidelines and regulations.
: Institutional consent forms were used.
: Prof. Dr. Poustka has received conference attendance support or speaking fees from Shire. She receives research funding from the BMBF, DFG and EU and royalties from Hogrefe, Kohlhammer and Schattauer. Prof. Dr. Roessner has received payment for consulting and writing activities from Lilly, Novartis, and Shire Pharmaceuticals, lecture fees from Lilly, Novartis, Shire Pharmaceuticals, and Medice Pharma, and support for research from Shire Pharmaceuticals and Novartis. He has carried out clinical trials in cooperation with the Novartis, Shire, Servier and Otsuka companies. The remaining authors declare no potential conflict of interest.
